Azenta, Inc. (NASDAQ:AZTA - Get Free Report) shares traded up 9.4% on Wednesday . The stock traded as high as $31.83 and last traded at $31.96. 266,414 shares were traded during trading, a decline of 66% from the average session volume of 775,144 shares. The stock had previously closed at $29.21.
Wall Street Analysts Forecast Growth
Several equities research analysts have recently weighed in on the company. Evercore ISI set a $33.00 price objective on Azenta and gave the stock an "in-line" rating in a research note on Tuesday, August 5th. Stephens initiated coverage on Azenta in a research report on Tuesday, July 22nd. They issued an "equal weight" rating and a $35.00 target price for the company. Raymond James Financial raised Azenta from a "market perform" rating to an "outperform" rating and set a $35.00 target price for the company in a research report on Wednesday, August 6th. Finally, Needham & Company LLC decreased their target price on Azenta from $59.00 to $40.00 and set a "buy" rating for the company in a research report on Wednesday, May 7th. Three equities research analysts have rated the stock with a hold rating and two have assigned a buy rating to the stock. Based on data from MarketBeat, the stock has an average rating of "Hold" and a consensus price target of $35.75.
Check Out Our Latest Stock Report on Azenta
Azenta Price Performance
The company has a fifty day simple moving average of $31.16 and a two-hundred day simple moving average of $33.98. The company has a market capitalization of $1.47 billion, a P/E ratio of -13.26 and a beta of 1.59.
Azenta (NASDAQ:AZTA - Get Free Report) last posted its earnings results on Tuesday, August 5th. The company reported $0.19 earnings per share for the quarter, beating the consensus estimate of $0.13 by $0.06. The company had revenue of $143.94 million for the quarter, compared to analyst estimates of $149.64 million. Azenta had a positive return on equity of 1.35% and a negative net margin of 18.45%. The business's revenue was up .0% compared to the same quarter last year. During the same period last year, the company earned $0.14 earnings per share. Equities analysts anticipate that Azenta, Inc. will post 0.53 earnings per share for the current year.
Hedge Funds Weigh In On Azenta
A number of institutional investors have recently made changes to their positions in the business. Mechanics Financial Corp lifted its position in shares of Azenta by 77.6% in the 2nd quarter. Mechanics Financial Corp now owns 870 shares of the company's stock worth $27,000 after acquiring an additional 380 shares during the period. Farther Finance Advisors LLC lifted its position in shares of Azenta by 788.1% in the 1st quarter. Farther Finance Advisors LLC now owns 968 shares of the company's stock worth $33,000 after acquiring an additional 859 shares during the period. CWM LLC lifted its position in shares of Azenta by 113.5% in the 2nd quarter. CWM LLC now owns 1,898 shares of the company's stock worth $58,000 after acquiring an additional 1,009 shares during the period. Allworth Financial LP lifted its position in shares of Azenta by 29.1% in the 2nd quarter. Allworth Financial LP now owns 2,050 shares of the company's stock worth $63,000 after acquiring an additional 462 shares during the period. Finally, Quarry LP bought a new stake in shares of Azenta in the 4th quarter worth approximately $110,000. 99.08% of the stock is currently owned by institutional investors.
Azenta Company Profile
(
Get Free Report)
Azenta, Inc provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates in two reportable segments, Life Sciences Products and Life Sciences Services.
Recommended Stories
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Azenta, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Azenta wasn't on the list.
While Azenta currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat's analysts have just released their top five short plays for August 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.